**Accreditation of the Genoa Biobank: A Significant Step Forward in Biobanking Biological Material**
The Genoa biobank dedicated to human genetics has recently achieved an important milestone: Accredia accreditation for the management of biological material of human origin. This recognition was obtained in accordance with the international standard UNI EN ISO 20387:2024, highlighting the facility’s commitment to the preservation and management of a wide range of biological samples. These samples come from individuals affected by genetic diseases and include various types of material, such as peripheral blood, serum, plasma, PBMC, urine, cerebrospinal fluid, genomic DNA, and cell lines.
This result represents a significant recognition not only for the Genoa biobank but also for the Italian biobanking system, as it is the second organization in the country to obtain this accreditation, following another biobank in Tuscany. The primary aim of this biobank is to systematically collect, preserve, and manage biological samples for subsequent distribution for research and development purposes. The importance of such operations is crucial in the field of scientific research, where the quality and traceability of samples can make a difference in the outcomes of investigations.
Research biobanks are tasked with a complex role: they must manage not only biological materials but also the associated clinical data, ensuring reproducibility and comparability of results. To this end, it is essential to follow standardized processes and procedures. Biobank users require guarantees regarding the proper handling of samples at all stages of the process, from collection to transport, and from preservation to distribution. In this context, accreditation according to the UNI ISO 20387:2019 standard represents a concrete response to the needs of the sector, establishing general requirements for competence, impartiality, and consistent operation of biobanking facilities.
An accredited biobank operates within a regulatory context that provides a broad framework, accepted internationally, for managing biological samples. This framework is crucial for those who wish to pursue an accreditation path, establishing guidelines that ensure high standards of quality and safety for the collection and management of biological material. The standard not only offers guidance to organizations working in the sector but also serves as a guarantor for users, ensuring trust in the protocols adopted.
The success of the Genoa biobank is part of a broader trend affecting both the national and international landscape, contributing to the development of research and biotechnology. The growing relevance of biobanks is evidenced by their ability to support innovative projects and scientific studies that can lead to important discoveries in the fields of health and well-being, especially regarding genetic diseases.
Biotechnology, an ever-expanding sector, plays an increasingly important role in the global economy. According to recent estimates, it is projected that by 2030, these technologies will account for a significant portion of the global gross domestic product, impacting at least 2.7%. This not only points to the scientific importance of biobanks but also to their economic and social influence, making them a fundamental pillar of future scientific and technological development.
The accreditation of the biobank is therefore an important step not only to ensure quality standards in sample management but also to strengthen Italy’s position in the context of global biomedical research. This achievement not only promotes scientific excellence but also opens new opportunities for collaboration and knowledge exchange among various research centers and institutions.
In conclusion, the recognition achieved by the Genoa biobank represents a positive evolution in the field of biobanking, contributing to an increasingly robust and cutting-edge research ecosystem. We invite readers to follow us on our social media profiles, where you can stay updated on the latest news and discoveries in the world of biotechnology and scientific research. Science is a journey.
